NCT07311746
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Leukemia, Prolymphocytic, T-Cell
Explore clinical trials studying Leukemia, Prolymphocytic, T-Cell. Study availability and eligibility vary by location and protocol.
25 public trials
9 recruiting studies
Leukemia, Prolymphocytic, T-Cell trial results
Recruiting
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
NCT06810778
- Conditions
- Cutaneous T-Cell Lymphoma Refractory, Disease Attributes, Hematologic Diseases, +16 more
- Locations
-
- David Geffen School of Medicine at the University of California at Los Angeles Los Angeles, California, United States
Recruiting
A Registry for People With T-cell Lymphoma
NCT05978141
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
- Locations
-
- City of Hope Cancer Center (Data collection only) Duarte, California, United States
- UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
- University of California San Francisco (Data collection only) San Francisco, California, United States
- Stanford University Medical Center (Data collection only) Stanford, California, United States
NCT04771572
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +48 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- University of North Carolina Chapel Hill, North Carolina, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
NCT07356245
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, Graft Versus Host Disease, +25 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT05010005
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
- Locations
-
- University of Miami (Data Collection Only) Miami, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
Recruiting
Registry of the German CLL Study Group
NCT02863692
- Conditions
- CLL, HCL, Hematologic Diseases, +19 more
- Locations
-
- BAG Freiberg-Richter, Jacobasch, Wolf, Illmer Dresden, Saxony, Germany
NCT04496349
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- MD Anderson Houston, Texas, United States
NCT06420076
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
- Locations
-
- District One Hospital Beijing, Beijing Municipality, China
Active, not recruiting
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
NCT05823571
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, CML, +34 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States